Full Text View
Tabular View
No Study Results Posted
Related Studies
A Study to Evaluate and Compare the Effectiveness and Metabolism of MK-0873 for the Treatment of Plaque Psoriasis (MK-0873-022-AM1)
This study has been completed.
Study NCT01235728   Information provided by Merck

First Received on November 4, 2010.   Last Updated on May 8, 2012   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Psoriasis
Plaque Psoriasis
More general conditions related to this trial
Skin Diseases
Skin Diseases, Papulosquamous
Interventions listed in this trial
2% MK-0873 Cream
MK-0873 vehicle (placebo)
Calcitriol
More general drug interventions related to this trial
Bone Density Conservation Agents
Calcium Channel Agonists
Cardiovascular Agents
Growth Substances
Membrane Transport Modulators
Micronutrients
Molecular Mechanisms of Pharmacological Action
Pharmacologic Actions
Physiological Effects of Drugs
Therapeutic Uses
Vasoconstrictor Agents
Vitamins
Sponsors listed in this trial
Merck


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services